Literature DB >> 14687717

Cytochrome P450 1A1 and manganese superoxide dismutase genes polymorphisms in reactive arthritis.

Jeng-Hsien Yen1, Wen-Chun Tsai, Chia-Hui Lin, Tsan-Teng Ou, Chaur-Jong Hu, Hong-Wen Liu.   

Abstract

To investigate the role of cytochrome P450 1A1 (CYP1A1) and manganese superoxide dismutase (Mn SOD) genes polymorphisms in the susceptibility to reactive arthritis, the polymorphisms of CYP1A1 and Mn SOD genes were determined in 43 patients with reactive arthritis following Chlamydia trachomatis infection and 92 healthy controls by polymerase chain reaction (PCR)/restriction fragment length polymorphisms (RFLP) method. The frequencies of CYP1A1 4887C/A and C/A+A/A were significantly higher in patients with reactive arthritis than in controls. Moreover, the increased frequency of CYP1A1 4887A in patients with reactive arthritis is independent of HLA-B27. The frequency of Mn SOD 1183T/T tended to be increased in patients with reactive arthritis. We also found that the frequency of CYP1A1 4887A was significantly increased in Mn SOD 1183T/T(+) reactive arthritis patients compared with 1183T/T(+) controls. CYP1A1 4887A may be a risk factor for the development of reactive arthritis, especially in the presence of Mn SOD 1183T/T.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14687717     DOI: 10.1016/j.imlet.2003.08.007

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Solute carrier family 11 member A1 gene polymorphisms in reactive arthritis.

Authors:  Yi-Jing Chen; Chia-Hui Lin; Tsan-Teng Ou; Cheng-Chin Wu; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

2.  Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach.

Authors:  Anukriti Verma; Shivani Sharda; Bhawna Rathi; Pallavi Somvanshi; Bimlesh Dhar Pandey
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.